Quest Diagnostics Inc vs Sea Limited — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Sea Limited trades at $129.5 (market cap $80.55B). The key difference: Sea Limited is far larger — about 3.1× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Sea Limited pays none. Which is the better fit depends on your goals.
| DGX | SE | |
|---|---|---|
Market Cap | $26.21B | $80.55B |
Sector | Health | Media |
52-Week High | $238.50 | $196.50 |
52-Week Low | $173.49 | $78.16 |
Enterprise Value | $31.97B | $75.58B |
Dividend Yield | 1.45% | — |
Trailing returns across standard periods
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Sea Limited offers information technology services. The Company provides online personal computer and mobile digital content, e-commerce, and payment platforms. Sea serves customers worldwide.
Read more on SE →